GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Short Interest

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Short Interest


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of ExpreS2ion Biotech Holding AB's Short Interest

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ExpreS2ion Biotech Holding AB's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's Short Interest distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's Short Interest falls into.


ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Short Interest
Comparable Companies
XSAT:ABERA NGM:COEGIN OSTO:COMBI OSTO:SCOL OSTO:LPGO OSTO:BIOSGN XSAT:CHOSA OSTO:2CUREX XSAT:RESP XSAT:APTA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5JD:Germany
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
Website
https://www.expres2ionbio.com
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines